![PPD figure 2[1].png](https://cdn.sanity.io/images/0vv8moc6/act/209e92e4f679d2a1d42544312ce717b002bbe8eb-838x382.png?w=350&fit=crop&auto=format)
Amid the recently released ICH E8 (R1) draft guidelines further supporting RBM strategies, practical methods for integrating critical-to-quality (CTQ) factors within the operational execution life cycle of a clinical trial are presented.
Brian Barnes
Advertisement
Articles by Brian Barnes
Using a risk-based model to navigate the inherent changes and fluctuations in master protocol studies-and help maintain data integrity throughout.
Advertisement
Latest Updated Articles
De-risking Master Protocol ImplementationPublished: June 1st 2019 | Updated:
![PPD figure 2[1].png](https://cdn.sanity.io/images/0vv8moc6/act/209e92e4f679d2a1d42544312ce717b002bbe8eb-838x382.png?w=300&fit=crop&auto=format)
Risk-Based Quality Management: The Importance of Risk CommunicationPublished: June 19th 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
3
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
4
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
